Clinical Trials Of Multiple Sclerosis Drug Shows It Can Reduce Rate Of Brain Shrinkage A clinical trial in the United States found that the experimental drug ibudilast can slow down brain atrophy in patients suffering from multiple sclerosis. The treatment went into Phase 2 testing and succeeded in a study sponsored by the NIH. by Diane Samson